Aim The aim of our study was to carry out a literature review and develop a model illustrating the domains of patients' lives that are impacted by herpes zoster (HZ) and subsequent chronic pain. Subjects and methods Biomedical databases and online congress archives were searched using keywords related to HZ or post-herpetic neuralgia (PHN) and social, psychological or physical impact. A total of 733 abstracts were reviewed, and 29 publications containing concepts reported by patients were retained for the model. Wilson and Cleary's model was used to organise the findings. Links between concepts were documented on three levels: hypothesis, observation and evidence. The final model illustrates the concepts impacted by HZ and PHN, relationships between these concepts and the level of evidence identified. Results The concepts identified from the articles were grouped into the following categories: biological/physiological, symptom status, functional status, health perceptions, characteristics of the individual, health-related quality of life (HRQOL), treatment and characteristics of the environment. Evidence exists showing that HZ-related pain directly impacts functional status, health perceptions and HRQOL. Conclusion Patients report that all major domains of life are impaired by HZ or subsequent chronic pain. HZ and its painful and debilitating complications can have a substantial impact on physical, psychological, social and role functioning, HRQOL and activities of daily living. The impact on elderly patients needs to be further assessed with appropriately designed and validated instruments, with specific attention paid to dependence.
Introduction
After primary infection with chickenpox, usually during childhood, the varicella zoster virus (VZV) becomes latent. Its reactivation causes herpes zoster (HZ), characterised by a painful vesicular rash and associated with substantial discomfort. It is often accompanied by spontaneous burning pain, parasthesias, itch and allodynia (Binder et al. 2008; Dwyer and Cunningham 2002; Fields et al. 1998; Schmader and Dworkin 2008) . HZ is a common illness, with an estimated lifetime incidence of 20 to 30% (Brisson and Edmunds 2003; Gauthier et al. 2008; Hope-Simpson 1965; . Its prevalence rises with age (Chapman et al. 2003; Gauthier et al. 2008; Bowsher 1999) ; the lifetime risk is estimated to increase to 50% in those aged >85 years (Miller et al. 1993; .
HZ can be associated with serious complications including post-herpetic neuralgia (PHN), encephalitis, HZ ophthalmicus, facial nerve paralysis, VZV retinitis, cornea affection and glaucoma (Dworkin et al. 2007; Oxman 2000; Schmader and Dworkin 2008) .
While PHN is the most frequent complication (Dworkin et al. 2007; Wareham and Breuer 2007) , its true incidence remains difficult to determine because of different definitions, methodologies and study populations. PHN persisting at 3 months after rash onset may occur in 10-20% of HZ patients aged over 50 years (Gauthier et al. 2008; Johnson and Rice 2007; Oxman et al. 2005; Scott et al. 2006) . The incidence of PHN also increases with age (Bowsher 1999; Goh and Khoo 1997) .
Patient-reported outcomes (PROs) can provide valuable data regarding the impact of disease as perceived by patients themselves. The term PRO refers to any healthrelated data collected directly from the patient (Acquadro et al. 2003) . These measures are increasingly used in clinical research (Marquis et al. 2006; Patrick et al. 2007) and are recognised as a way of reliably and validly assessing symptoms such as pain, functional limitations and healthrelated quality of life (HRQOL) to supplement standard clinical and physiological criteria (Schipper 1990; Spilker 1990; Wilson and Cleary 1995) .
The patients' perspective is recognised as particularly relevant in painful conditions (Human Use and CHMP 2007) ; it is acknowledged that painful chronic conditions are a major cause of impaired HRQOL (Vetter 2007) . The level of pain experienced by patients with HZ or PHN can be very high , and thus is likely to impact patients' daily lives, especially in the elderly. As existing treatments do not adequately control pain in a large proportion of patients (Wu and Raja 2008; Rowbotham and Petersen 2001) , the assessment of disease burden is particularly interesting in this population.
The aim of this study was to systematically review the published research on the impact of HZ and PHN from the patients' perspective. The specific objectives of the work were to: (1) list all domains of patients' lives reported as impaired by HZ and PHN; (2) identify the hypothesised relationships between these domains; (3) assess the level of published evidence supporting the causality of HZ and PHN in these impairments.
Methods

Systematic literature review
Information sources
The search was conducted in March 2007, exploring MEDLINE, EMBASE and PsycINFO, and 
Search strategy
Search criteria were defined as follows: articles written in English and including an abstract, published since 1980 and reporting on the adult population. The searches were carried out using a combination of the following Medical Subject Headings (MeSH): herpes zoster, post-herpetic neuralgia, quality of life, psychological adaptation, pain measurement, activities of daily living, patient satisfaction, health status and cost of illness, and the following non-MeSH keywords: functioning, conceptual framework, and impact social, dependence, symptoms and instrumental activities of daily living.
Abstract selection
Selection and rejection criteria were determined as follows: abstracts were retained if they mentioned either PRO concepts related to the impact of HZ, PHN or neuropathic pain on patients' lives, or questionnaires measuring patients' perspectives on these impacts. Abstracts reporting environmental or patient characteristics related to the occurrence, frequency or severity of HZ or PHN were also retained. Abstracts were rejected if they were not specific to HZ, PHN or neuropathic pain, if only clinical pain was described or if the study presented did not mention PRO concepts or questionnaires. Seven hundred thirty-three abstracts were retrieved and reviewed by two researchers independently. Abstracts were selected when an agreement between them was reached. Six hundred thirty-six abstracts did not meet the selection criteria, or met one of the rejection criteria and were rejected.
Article selection
Ninety-seven articles were ordered and reviewed in detail. Sixty-eight articles were rejected for one of the following reasons: the target population was not clearly defined, concepts impacted by HZ or PHN were not mentioned, or the studies did not include instruments measuring the impact of HZ or PHN on patients.
Twenty-nine articles were selected for inclusion in the models. Relevant data from the final set of articles selected were recorded in specific extraction tables. From each article, detailed information was retained on the aim of the study, the population, the country, the questionnaires used and the PRO concepts.
Development of the models
The information extracted from the selected articles was used to develop two models about the impact of HZ and PHN on patients' lives: a first one providing an organised summary of all concepts identified-the descriptive model-and a second one showing only published evidence on causal relationships between these concepts-the causal model.
Selection of concepts and development of the descriptive model
The data extracted from the articles were used to develop a comprehensive model illustrating the impact of HZ and PHN on patients' lives. Wilson and Cleary's model (1995) was taken as a basis for the structure of our models. The model developed by Wilson and Cleary contains five central domains that are likely to be impacted by a disease or disorder: biological and physiological variables, symptom status, functional status, general health perceptions and overall quality of life. In addition to these, factors that can influence the impact of disease on patients' lives are grouped in two other general domains: characteristics of the individual and characteristics of the environment. All of the PRO concepts identified in the selected articles were organised according to these domains to develop a specific descriptive model of HZ and PHN. One specific new domaintreatment-was added in order to complete the picture.
Assessment of evidence level and development of the causal model
The causal relationship between the concepts was then studied at three levels of evidence: tested hypothesis, observed information or hypothesis. Causal relationships supported by positive statistical testing of predefined hypotheses that were listed among the study objectives were categorised as tested hypothesis; other causal relationships supported by the study data (correlations or tests) were categorised as observed information; causal relationships mentioned in the introduction or discussion of the article, but not supported by the study data, were categorised as hypotheses. The causal model that was then developed to illustrate the relationships includes only the domains and concepts for which the highest level of evidence (tested hypothesis) was identified in the form of results from a population-based study.
Results
The PRO questionnaires that were referenced in the publications included in the review can be found in Table 1 .
The questionnaires are listed according to the domains measured, which are: characteristics of the individual, symptom status, functional status, health perceptions, characteristics of the environment and QOL. The publications in which these questionnaires were cited or used are referenced in the table.
Descriptive model
The model details the concepts identified from the literature search, irrespective of the level of evidence provided by the authors. It is organised into eight distinct domains: characteristics of the individual, biological/physical, symptoms status, functional status, health perceptions, characteristics of the environment, HRQOL and treatment. Each domain contains a number of general concepts identified in the referenced articles. Figure 1 is the descriptive model of all of these domains and general concepts. Symptoms associated with HZ and PHN comprised pain, rash, cutaneous manifestations, fever and discomfort. Beyond these symptoms, HZ and PHN had negative effects on physical functioning, activities of daily living, psychological and social functioning, including well-being (van , depression , social isolation and withdrawal .
Causal model
When the relationship among the different domains was studied in detail, the domains found to be directly impacted by HZ pain and PHN were: functional status Lydick et al. 1995; Mauskopf et al. 1994; van Seventer et al. 2006) , health perceptions (van and HRQOL (Chidiac et al. 2001; Katz et al. 2004; Lydick et al. 1995; Mauskopf et al. 1994; van Seventer et al. 2006) . Figure 2 is the model illustrating these relationships. Functional status contains basic functions such as sleep and physical mobility, directly impacted by HZ pain and PHN. It also includes physical function, which is affected to the extent of interfering with activities of daily living. The health perceptions domain is affected in terms of the health status of patients. HRQOL comprises complex concepts such as depression and psychological impairment, as well as serious social impacts such as social withdrawal and isolation. The functional and social impacts of this pain pose a longer term threat to patients, and can lead to limitations and handicaps, especially in the elderly . In old age, patients become vulnerable to acute diseases and harmful events, which are likely to trigger a shift to dependence.
Other clinical factors such as fatigue and depression in addition to pain are reported to impact patients' lives, such as crusting and healing . However, the level of available evidence regarding to what extent these have specific detrimental effects is not as strong as it is for pain.
Direct costs for medical treatment of HZ and PHN are high, and the functional, psychological, social and further 
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Discussion and conclusions
With the rapid expansion of the elderly population in Western countries (Giannakouris 2008) , the prevalence of HZ is expected to continue to rise, and public health policies must be adapted to the actual severity of these conditions. A literature review is not experimental research. During the process of accessing sources, selecting articles, extracting the useful information and organising it, various biases are likely to occur. In order to optimise the reliability and reproducibility of our findings, we applied a systematic approach at each stage of our work: selection of sources, extraction of data and analysis. A comprehensive descriptive model and a causal model were developed from the systematic literature review. The level of available evidence in the causal model relationships was assessed according to predefined rules that enabled the relationships between the concepts to be categorised as tested hypothesis, observed information or hypotheses. The first model highlighted the impact of HZ and PHN symptoms on all aspects of the patients' lives. As such, it fits remarkably well with the generic model developed by Wilson and Cleary that describes the relationships between clinical parameters and HRQOL (Wilson and Cleary 1995) . HZ pain and PHN were identified as the trigger of every causal relationship and the only element of the symptoms status domain for which sufficient evidence was identified. The causal model gave evidence of relationships between symptoms status, functional status, health perceptions and HRQOL.
Although HZ and PHN have been less studied from the patients' perspective than other common painful conditions, the scientific literature shows consensus on the impact these conditions have on patients' lives. The critical role of pain in HZ and PHN is consistent with findings in various other painful diseases and conditions, where pain has been identified as the primary cause of negative effects on several functions (Neumann et al. 2000; Wolfe and Hawley 1997) . With pain episodes that are frequently reported by these patients to be particularly severe, pain is considered the major driver of impairment in functioning, health perceptions and HRQOL. The descriptive and causal models suggest that the combination of impaired physical, psychological and social functioning resulting from HZ and PHN is likely to have irreversible consequences on patients' lives after a certain age. However, to our knowledge, no epidemiological data are available on the impact of HZ or PHN episodes on institutionalisation rates or other indicators or measures of dependence.
As regards the other non-painful symptoms, even if they have been reported to impact patients' lives, further research needs to be conducted to confirm these assumptions and assess the magnitude of the specific impact non-painful symptoms have on patients' lives.
Economic and epidemiologic data confirm the importance of unmet needs in the current management of HZ and PHN ). Moreover, the economic consequences of these conditions are exacerbated as an episode of PHN can be lengthy: after 1 year, 5%-10% of patients still experience pain .
Pain being a lasting symptom in particular of PHN, it is one of the main targets of pharmacologic treatment (Johnson et al. 2008) . However, the specific vulnerability of the elderly, for whom temporary dysfunction easily turns into permanent disability, highlights the need for strategies centred not on this specific symptom but on the patient. Recent recommendations for HZ management include broader non-pharmacologic approaches such as social support and patient education (Schmader and Dworkin 2008) ; (Wu and Raja 2008) , especially for the elderly (Dworkin et al. 2007 ). An alternative to therapeutic strategy is prevention and early treatment of HZ in order to lower the incidence of PHN. The prevention of HZ is expected to reduce the costs associated with HZ and PHN (Cunningham et al. 2008) . A HZ vaccine has proven effective in reducing the incidence and severity of HZ and PHN, especially in individuals aged >60 (Oxman and Levin 2008) . Vaccination was also associated with improvements in key patient-reported domains such as a reduced interference with activities of daily living (Gnann 2008) . Further long-term population-based studies are expected in order to examine the epidemiological impact of these vaccination programmes.
A number of generic and specific PRO questionnaires have been developed, validated and used in clinical research to provide a means of assessing the patient's perspective in various diseases and conditions (Chassany et al. 2002) . Only a few specific measures have been developed to assess the impact of HZ and PHN as perceived by the patients, including the Zoster Brief Pain Inventory (Coplan et al. 2004 ) and the Zoster Impact Questionnaire ). However, studies identified in the present analysis often used questionnaires that are not specific to the population or to the disease area being considered. Specific measurement instruments need to be developed and validated for an adequate, reliable and sensitive assessment of these changes, especially in elderly people.
Additional research is needed to complete and consolidate the picture of the detrimental effect of HZ and PHN on patients' lives: first, prospective longitudinal studies are needed to provide estimates of the impact of painful episodes and to quantify how much this impact can be limited with new strategies, such as prevention; then, the assumption regarding the impact of HZ and PHN on the level of dependence-an assumption that is strongly supported by the impact models based on published dataneeds to be confirmed and quantified by specific epidemiological studies.
One limitation that could be raised for this literature review is the approximate labelling or naming of concepts and the lack of appropriate definitions are a source of confusion that frequently surrounds many of the concepts that are dealt with in the literature; the most common confusion lies in the misuse of the term "quality of life" as an umbrella term for patient-related symptoms, function, HRQOL and health status, whereas quality of life is a specific notion with recognised definitions (Schipper 1990; Spilker 1990 ). Despite our awareness of the risk of confusion resulting from the terms used, the models proposed in the present article provide an organisation of the PRO concepts based on the original terminology used by the authors of the selected publications, even when the concepts were not explicitly defined or illustrated with items showing face validity.
